CVS Health is launching a prescription savings program with Novo Nordisk that will offer discounts on certain medications.
Reduced Rx is expected to help people with high out-of-pocket costs afford essential medications such as Novo Nordisk insulins Novolin R and Novolin N, at a cost of $25 per 10 mL vial. This could save users as much as $100, according to a Novo Nordisk press release.
Enrollment for the program will begin in May. People using Reduced Rx will need to pay the cost of the medication out of pocket, according to the release. The program cannot be used with prescription drug insurance coverage.
“We developed the Reduced Rx prescription savings program with Novo Nordisk because we both recognized a need and an opportunity to make critical medications more affordable for patients,” Jonathan Roberts, executive vice president and chief operating officer of CVS Health said in the release. “This savings program will leverage CVS Caremark’s expertise in providing lower cost prescription drugs and fulfill our company’s purpose of helping people on their path to better health."
